A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

Research output: Contribution to journalArticlepeer-review


  • Alan K. Burnett
  • Robert K. Hills
  • O. J. Nielsen
  • A. Ali
  • P. Cahalin
  • A. Hunter
  • I. F. Thomas
  • N. H. Russell

Colleges, School and Institutes

External organisations

  • Cardiff University
  • Copenhagen University Hospitals
  • Castle Hill Hospital
  • Blackpool Victoria Hospital
  • Leicester Royal Infirmary
  • Nottingham University Hospitals NHS Trust


Original languageEnglish
Number of pages5
Early online date6 Jun 2018
Publication statusPublished - 31 Dec 2018